| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_494b5081343118ce6d9f271a6dc7cefd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate |
1998-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee95a603e159cfddb581f82b3902948 |
| publicationDate |
1999-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9959632-A1 |
| titleOfInvention |
Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| abstract |
The present invention is directed to methods for treating asthmatic, allergic, and Th2-mediated inflammation conditions by administering a product having TNF-RII(p75) agonist properties to a human or an animal. The use of products having TNF-RII(p75) agonist properties for the preparation of pharmaceutical compositions for treating bronchial asthma, allergic and Th2-mediated inflammation conditions in humans or animals is also provided by the invention, as well as a method for screening products having TNF-RII(p75) agonist properties comprising monitoring the inhibition of pulmonary inflammation occuring in humans or animals having pulmonary inflammation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9840556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10906982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9821010-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2853588-A1 |
| priorityDate |
1998-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |